Vera Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Vera Therapeutics has a total shareholder equity of $101.7M and total debt of $49.9M, which brings its debt-to-equity ratio to 49.1%. Its total assets and total liabilities are $175.5M and $73.9M respectively.
Key information
49.1%
Debt to equity ratio
US$49.88m
Debt
Interest coverage ratio | n/a |
Cash | US$160.72m |
Equity | US$101.69m |
Total liabilities | US$73.86m |
Total assets | US$175.55m |
Recent financial health updates
Companies Like Vera Therapeutics (NASDAQ:VERA) Are In A Position To Invest In Growth
Feb 16We Think Vera Therapeutics (NASDAQ:VERA) Can Afford To Drive Business Growth
Oct 25Recent updates
Vera Therapeutics: Soaring On IgAN Data, But Full Approval A Distant Prospect
Jan 25Vera Therapeutics: Under The Radar IgAN Player Has Much To Prove
Sep 06Vera Therapeutics GAAP EPS of -$0.55 beats by $0.17
Aug 10Companies Like Vera Therapeutics (NASDAQ:VERA) Are In A Position To Invest In Growth
Feb 16Vera: Biotech With 3 Mid-Stage Programs With Potential For Success
Jan 19Vera Therapeutics: Surprising Pivot To A Kidney Disease Drug Looks Like A Long Shot
Jan 07We Think Vera Therapeutics (NASDAQ:VERA) Can Afford To Drive Business Growth
Oct 25Vera Therapeutics soars 16% on three new favorable view from analysts
Jun 08Financial Position Analysis
Short Term Liabilities: VERA's short term assets ($172.0M) exceed its short term liabilities ($22.3M).
Long Term Liabilities: VERA's short term assets ($172.0M) exceed its long term liabilities ($51.6M).
Debt to Equity History and Analysis
Debt Level: VERA has more cash than its total debt.
Reducing Debt: Insufficient data to determine if VERA's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VERA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: VERA has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 38.7% each year.